AtriCure, Inc.
ATRC
$32.43
-$0.28-0.86%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 480.08M | 465.31M | 447.57M | 429.95M | 414.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 480.08M | 465.31M | 447.57M | 429.95M | 414.60M |
| Cost of Revenue | 121.19M | 117.78M | 112.85M | 108.16M | 102.57M |
| Gross Profit | 358.88M | 347.52M | 334.72M | 321.80M | 312.03M |
| SG&A Expenses | 295.07M | 291.36M | 286.86M | 275.23M | 265.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 515.13M | 505.32M | 481.73M | 464.80M | 446.83M |
| Operating Income | -35.05M | -40.01M | -34.16M | -34.84M | -32.23M |
| Income Before Tax | -37.10M | -43.67M | -37.79M | -39.27M | -36.54M |
| Income Tax Expenses | 1.08M | 1.02M | 1.13M | 856.00K | 696.00K |
| Earnings from Continuing Operations | -38.18 | -44.70 | -38.92 | -40.12 | -37.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.18M | -44.70M | -38.92M | -40.12M | -37.23M |
| EBIT | -35.05M | -40.01M | -34.16M | -34.84M | -32.23M |
| EBITDA | -15.69M | -21.28M | -16.07M | -17.57M | -15.91M |
| EPS Basic | -0.81 | -0.95 | -0.83 | -0.86 | -0.80 |
| Normalized Basic EPS | -0.49 | -0.56 | -0.49 | -0.51 | -0.48 |
| EPS Diluted | -0.81 | -0.95 | -0.83 | -0.86 | -0.80 |
| Normalized Diluted EPS | -0.49 | -0.56 | -0.49 | -0.51 | -0.48 |
| Average Basic Shares Outstanding | 188.53M | 187.86M | 187.18M | 186.49M | 185.84M |
| Average Diluted Shares Outstanding | 188.53M | 187.86M | 187.18M | 186.49M | 185.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |